BIOCRYST PHARMACEUTICALS, INC. (BCRX)

Import this data to Google Sheets with:

=jivedata("BCRX","financials")

Full statements spill as a table. For one cell: =jivedata("BCRX","Revenue") or =jivedata("BCRX","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

BIOCRYST PHARMACEUTICALS, INC.

BCRX • CIK 0000882796

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Cash and Cash Equivalents, at Carrying Value	$110,643	$104,713	$89,736	$154,972
Restricted Cash and Cash Equivalents, Current	$1,804	$210	$201	$479
Inventory, Noncurrent	—	$23,187	$23,990	$31,945
Short-term Investments	—	—	$185,011	$197,601
Property, Plant and Equipment, Net	$7,910	$7,777	$8,783	$9,058
Accounts Receivable, after Allowance for Credit Loss, Current	$56,950	$79,069	$106,818	$110,757
Long-term Investments	$0	$20,323	$61,164	$0
Inventory, Net	$28,683	$31,274	$5,398	$6,056
Prepaid Expense and Other Assets, Current	$19,542	$13,752	$17,182	$14,818
Other Assets, Noncurrent	$13,084	$5,157	$5,672	$19,557
Assets, Current	$495,966	$421,968	$404,346	$484,683
Assets	$516,960	$490,420	$514,158	$557,851
Operating Lease, Liability, Noncurrent	$8,390	$7,924	$8,571	$10,603
Finance Lease, Liability, Noncurrent	$2,845	$2,124	$1,441	$849
Long-term Debt, Excluding Current Maturities	$303,231	$314,869	$0	$395,400
Liabilities	—	$966,354	$633,311	$1,012,140
Accounts Payable, Current	$20,893	$11,644	$15,826	$11,459
Accrued Liabilities, Current	$102,882	$113,292	$126,413	$121,895
Operating Lease, Liability, Current	$1,058	$937	$317	$1,912
Finance Lease, Liability, Current	$1,590	$1,835	$1,312	$1,092
Liabilities, Current	$149,988	$160,384	$196,066	$208,846
Preferred Stock, Value, Issued	$0	$0	$0	$0
Common Stock, Value, Issued	$2,058	$2,085	$2,131	$2,553
Additional Paid in Capital	$1,222,236	$1,291,100	$1,384,857	$1,693,282
Accumulated Other Comprehensive Income (Loss), Net of Tax	$1,337	$921	$38	$-528
Retained Earnings (Accumulated Deficit)	$-1,681,159	$-1,770,040	$-1,506,179	$-2,149,596
Stockholders' Equity Attributable to Parent	$-455,528	$-475,934	$-119,153	$-454,289
Preferred Stock, Shares Authorized	5,000,000	5,000,000	5,000,000	5,000,000
Preferred Stock, Shares Issued	—	—	0	0
Preferred Stock, Shares Outstanding	0	0	0	0
Common Stock, Shares Authorized	450,000,000	450,000,000	450,000,000	450,000,000
Common Stock, Shares, Issued	205,771,000	208,543,000	213,060,000	255,265,000

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Net Income (Loss) Attributable to Parent	$-226,539	$-88,881	$263,861	$-384,673
Net Cash Provided by (Used in) Operating Activities	$-95,141	$-52,020	$347,369	$376,135
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$362	$-936	$1,270	$-647
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$-193,792	$-6,124	$-14,986	$66,459
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	—	—	$91,337	$157,834
Depreciation, Depletion and Amortization	$1,655	$1,246	$1,389	$1,389
Payments to Acquire Productive Assets	$2,168	$1,124	$2,468	$2,758
Inventory Write-down	$422	$1,350	$985	$542
Payments to Acquire Debt Securities, Available-for-sale	$514,407	$266,763	$262,240	$319,772
Share-based Payment Arrangement, Noncash Expense	$55,615	$65,413	$85,066	$73,113
Proceeds from Sale and Maturity of Debt Securities, Available-for-sale	$385,077	$320,480	$256,647	$368,931
Proceeds from Sale of Other Assets, Investing Activities	—	—	$550	$550
Proceeds from Divestiture of Businesses, Net of Cash Divested	—	—	$-6,183	$-6,183
Net Cash Provided by (Used in) Investing Activities	$-131,498	$52,593	$-13,694	$-448,712
Gain (Loss) on Extinguishment of Debt	$-29,019	$0	$-17,332	$-13,161
Tangible Asset Impairment Charges	$1,548	$0	$0	$0
Gain (Loss) on Disposition of Business	—	—	$3,566	$3,566
Increase (Decrease) in Receivables	$6,095	$22,698	$36,806	$17,470
Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised	$8,340	$3,444	$9,115	$28,986
Increase (Decrease) in Inventories	$1,450	$4,164	$1,639	$11,403
Payment, Tax Withholding, Share-based Payment Arrangement	$2,172	$7,535	$8,847	$11,509
Increase (Decrease) in Prepaid Expense and Other Assets	$6,820	$-1,959	$7,827	$-109
Proceeds from Issuance of Long-term Debt	$300,000	$0	$0	$400,000
Increase (Decrease) in Accounts Payable	$-16,806	$-62,379	$57,802	$4,607
Repayments of Long-term Debt	—	—	$300,000	$230,492
Increase (Decrease) in Contract with Customer, Liability	$-1,230	$0	$0	$10,793
Payment for Debt Extinguishment or Debt Prepayment Cost	—	—	$9,886	$7,636
Payments of Debt Issuance Costs	$11,147	$0	$0	$4,952
Finance Lease, Principal Payments	$1,165	$1,704	$1,989	$1,643
Net Cash Provided by (Used in) Financing Activities	$32,485	$-5,761	$-349,931	$124,625
Cash and Cash Equivalents, at Carrying Value	$110,643	$104,713	$89,736	$156,137
Restricted Cash and Cash Equivalents, Current	$1,804	$210	$201	$764
Interest Paid, Excluding Capitalized Interest, Operating Activities	$22,139	$30,383	$23,735	$21,430
Capital Expenditures Incurred but Not yet Paid	—	—	$608	$1,216

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("BCRX","financials")

Full statements spill as a table. For one cell: =jivedata("BCRX","Revenue") or =jivedata("BCRX","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.